European Food Safety Authority (EFSA), Dimosthenis Sarigiannis, Manca Ahačič, Anne Mette Zenner Boisen, Francesco Capozzi, Mark Cassar, Mariana Fernández, Marcel Mengelers, Mattias Öberg, Elliott James Price, Gilles Rivière, Milada Syčová, Tewes Tralau, Georgieva Tzveta, Ilse Van Overmeire, Susana Viegas, Ivana Vinković Vrček, Karolina Žiogelytė, Zainab Al Harraq, Mina Ristovska, Lucian Farcal
{"title":"2025 Annual Report of the Advisory Group on Biomarkers of Effect","authors":"European Food Safety Authority (EFSA), Dimosthenis Sarigiannis, Manca Ahačič, Anne Mette Zenner Boisen, Francesco Capozzi, Mark Cassar, Mariana Fernández, Marcel Mengelers, Mattias Öberg, Elliott James Price, Gilles Rivière, Milada Syčová, Tewes Tralau, Georgieva Tzveta, Ilse Van Overmeire, Susana Viegas, Ivana Vinković Vrček, Karolina Žiogelytė, Zainab Al Harraq, Mina Ristovska, Lucian Farcal","doi":"10.2903/sp.efsa.2026.EN-10047","DOIUrl":null,"url":null,"abstract":"<p>The 2025 Annual Report of the Advisory Group on Biomarkers of Effect (AGoB) details the group's establishment, objectives, and activities in supporting EFSA's development of guidance on biomarkers of effect (BoEs) in regulatory risk assessment. The report outlines AGoB's collaborative efforts, meeting summaries, scientific advice and plans for future work.</p>","PeriodicalId":100395,"journal":{"name":"EFSA Supporting Publications","volume":"23 3","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2026-03-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://efsa.onlinelibrary.wiley.com/doi/epdf/10.2903/sp.efsa.2026.EN-10047","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"EFSA Supporting Publications","FirstCategoryId":"1085","ListUrlMain":"https://efsa.onlinelibrary.wiley.com/doi/10.2903/sp.efsa.2026.EN-10047","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
The 2025 Annual Report of the Advisory Group on Biomarkers of Effect (AGoB) details the group's establishment, objectives, and activities in supporting EFSA's development of guidance on biomarkers of effect (BoEs) in regulatory risk assessment. The report outlines AGoB's collaborative efforts, meeting summaries, scientific advice and plans for future work.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
